| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |